CTSN Embolic Protection Trial (EMPRO)
Embolic Protection in Patients Undergoing High-Risk Valve Surgery
Sponsor: Icahn School of Medicine at Mount Sinai
Listed as NCT06027788, this NA trial focuses on Acute Kidney Injury and Coronary Artery Disease and remains actively recruiting participants. Sponsored by Icahn School of Medicine at Mount Sinai, it has been updated 10 times since 2023, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Aug 2025 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2025 — Aug 2025 [monthly]
Recruiting NA
-
Apr 2025 — Jul 2025 [monthly]
Recruiting NA
-
Mar 2025 — Apr 2025 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
-
Nov 2023 — Mar 2024 [monthly]
Recruiting NA
-
Oct 2023 — Nov 2023 [monthly]
Recruiting NA
First recorded
Sep 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .